These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23403397)

  • 1. Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging.
    Ye M; Qian Y; Tang J; Hu H; Sui M; Shen Y
    J Control Release; 2013 Aug; 169(3):239-45. PubMed ID: 23403397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.
    Cao Y; Zu G; Kuang Y; He Y; Mao Z; Liu M; Xiong D; Pei R
    ACS Appl Mater Interfaces; 2018 Aug; 10(32):26906-26916. PubMed ID: 30028584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent.
    Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C
    Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing MRI of liver metastases with a zwitterionized biodegradable dendritic contrast agent.
    Zhou X; Ye M; Han Y; Tang J; Qian Y; Hu H; Shen Y
    Biomater Sci; 2017 Jul; 5(8):1588-1595. PubMed ID: 28422200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Hyperbranched Polylysine as Potential Contrast Agent Probes for Magnetic Resonance Imaging.
    Zu G; Liu M; Zhang K; Hong S; Dong J; Cao Y; Jiang B; Luo L; Pei R
    Biomacromolecules; 2016 Jun; 17(6):2302-8. PubMed ID: 27187578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
    Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
    MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.
    Mohs AM; Wang X; Goodrich KC; Zong Y; Parker DL; Lu ZR
    Bioconjug Chem; 2004; 15(6):1424-30. PubMed ID: 15546211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM.
    Miyake Y; Ishikawa S; Kimura Y; Son A; Imai H; Matsuda T; Yamada H; Toshimitsu A; Kondo T
    Sensors (Basel); 2015 Dec; 15(12):31973-86. PubMed ID: 26694418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.
    Zong Y; Wang X; Goodrich KC; Mohs AM; Parker DL; Lu ZR
    Magn Reson Med; 2005 Apr; 53(4):835-42. PubMed ID: 15799038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
    Zong Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Magn Reson Imaging; 2009 May; 27(4):503-11. PubMed ID: 18814987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
    Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
    Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligoethylenimine-grafted chitosan as enhanced T1 contrast agent for in vivo targeted tumor MRI.
    Tong X; Liu M; Zhang K; Cao Y; Dong J; Jiang B; Lu B; Zheng H; Zhang H; Pei R
    J Magn Reson Imaging; 2016 Jul; 44(1):23-9. PubMed ID: 26713668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent.
    Dai Y; Wu C; Wang S; Li Q; Zhang M; Li J; Xu K
    Nanomedicine; 2018 Feb; 14(2):547-555. PubMed ID: 29253637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.
    Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z
    Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
    Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
    J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.
    Xu R; Wang Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1081-9. PubMed ID: 17720954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
    Kobayashi H; Kawamoto S; Jo SK; Bryant HL; Brechbiel MW; Star RA
    Bioconjug Chem; 2003; 14(2):388-94. PubMed ID: 12643749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.